The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis

Clinical Rheumatology

Volumn 29, Issue 3, 2010, Pages 303-307

  Karkucak, Murat ^a   Capkin, Erhan ^a   Alver, Ahmet ^a   Akyuz, Ayse ^a   Kiris, Abdulkadir ^a   Ak, Emel ^a   Topbas, Murat ^a   Tosun, Mehmet ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Ankylosing spondylitis; Anti TNF agent; Oxidation status

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; CHOLESTEROL; ETANERCEPT; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR INHIBITOR; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGE; ANKYLOSING SPONDYLITIS; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTICLE; BODY MASS; CALCULATION; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENDER; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; TREATMENT DURATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; RECEPTORS, TUMOR NECROSIS FACTOR; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950598170     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1325-6     Document Type: Article

References (26)

1. Arnett FC (2001) Ankylosing spondylitis. In: Koopman WJ (ed) Arthritis and allied conditions. Philadelphia: Lippincott Williams and Wilkins, pp 1311-1323
2. S Sarban A Kocyigit M Yazar UE Isikan 2005 Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis Clin Biochem 38 11 981 986 10.1016/j.clinbiochem.2005.08.003 1:CAS:528:DC%2BD2MXht1SqsLzJ 16150434 (Pubitemid 41606795)
3. DO Stichtenoth J Wollenhaupt D Andersone H Zeidler JC Frölich 1995 Elevated serum nitrate concentrations in active spondyloarthropathies Br J Rheumatol 34 7 616 619 10.1093/rheumatology/34.7.616 1:STN:280: DyaK2MvgtVKmsg%3D%3D 7670778
4. S Ozgocmen S Sogut O Ardicoglu E Fadillioglu I Pekkutucu O Akyol 2004 Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis Rheumatol Int 24 80 83 10.1007/s00296-003-0335-y 1:CAS:528:DC%2BD2cXhsl2gt7g%3D 12811507 (Pubitemid 38388749)
5. C Yazici K Köse M Calis S Kuzugüden M Kirnap 2004 Protein oxidation status in patients with ankylosing spondylitis Rheumatology (Oxford) 43 10 1235 1239 10.1093/rheumatology/keh317 1:CAS:528:DC%2BD2cXnvVOqsrw%3D (Pubitemid 39359296)
6. G Cunnane B Bresnihan O FitzGerald 1998 Immunohistologic analysis of peripheral joint disease in ankylosing spondylitis Arthritis Rheum 41 180 182 10.1002/1529-0131(199801)41:1<180::AID-ART24>3.0.CO;2-V 1:STN:280:DyaK1c%2Fptl2ktg%3D%3D 9433885 (Pubitemid 28041939)
7. J Braun T Pham J Sieper J Davis S van der Linden M Dougados, et al. 2003 International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. ASAS working group Ann Rheum Dis 62 9 817 824 10.1136/ard.62.9.817 1:CAS:528:DC%2BD3sXns1SisLg%3D 12922952 (Pubitemid 37026490)
8. I Sari T Okan S Akar H Cece C Altay M Secil, et al. 2006 Impaired endothelial function in patients with ankylosing spondylitis Rheumatology (Oxford) 45 3 283 286 10.1093/rheumatology/kei145 1:STN:280: DC%2BD287gt1Sguw%3D%3D (Pubitemid 43372841)
9. S Van der Linden HA Valkenburg A Cats 1984 Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria Arthritis Rheum 27 361 368 10.1002/art.1780270401 6231933 (Pubitemid 14134775)
10. A Calin JP Nakache A Gueguen H Zeidler H Mielants M Daugados 1999 Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 38 878 882 10.1093/rheumatology/38.9.878 1:STN:280:DyaK1MvktlKksQ%3D%3D 10515650 (Pubitemid 29507371)
11. M Rabus R Demirbaǧ Y Sezen O Konukoǧlu A Yildiz O Erel, et al. 2008 Plasma and tissue oxidative stress index in patients with rheumatic and degenerative heart valve disease Turk Kardiyol Dern Ars 36 8 536 540 19223719
12. PP Tak NJ Zvaifler DR Green GS Firestein 2000 Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases Immunol Today 21 2 78 82 10.1016/S0167-5699(99)01552-2 1:CAS:528: DC%2BD3cXpsFGrsg%3D%3D 10652465 (Pubitemid 30069620)
13. D Wendling JM Didier DA Vuitton 1991 The phagocyte oxidative metabolism function in ankylosing spondylitis Rheumatol Int 11 4-5 187 189 10.1007/BF00332560 1:STN:280:DyaK387ltVyltw%3D%3D 1664542
14. OV Mitrofanova VV Bagirova SI Krasikov 2002 Levels of lipid peroxidation products and activity of antiradical defense enzymes in blood of patients with Bechterew disease Ter Arkh 74 5 66 69 1:STN:280:DC%2BD38zksVOjtA%3D%3D 12087912
15. M Karakoc O Altindag H Keles N Soran S Selek 2007 Serum oxidative-antioxidative status in patients with ankylosing spondylitis Rheumatol Int 27 12 1131 1134 10.1007/s00296-007-0352-3 1:CAS:528:DC%2BD2sXhtVSisLbL 17443328 (Pubitemid 47373938)
16. J Braun X Baraliakos J Listing J Sieper 2005 Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept Arthritis Rheum 52 8 2447 2451 10.1002/art.21197 1:CAS:528:DC%2BD2MXpslGht70%3D 16052578 (Pubitemid 41117431)
17. S Pay U Musabak H Erdem I Simsek A Pekel A Sengul, et al. 2005 Chimerical anti-TNF-alpha, infliximab, inhibits neutrophil chemotaxis and production of reactive oxygen species by blocking the priming effect of mononuclear cells on neutrophils Immunopharmacol Immunotoxicol 27 2 187 198 10.1081/IPH-200067702 1:CAS:528:DC%2BD2MXpslSrsb8%3D 16114504 (Pubitemid 41098451)
18. AA den Broeder GJ Wanten WJ Oyen T Naber PL van Riel P Barrera 2003 Neutrophil migration and production of reactive oxygen species during treatment with a fully human anti-tumor necrosis factor-alpha monoclonal antibody in patients with rheumatoid arthritis J Rheumatol 30 2 232 237 (Pubitemid 36152582)
19. L Prónai Y Ichikawa K Ichimori H Nakazawa S Arimori 1991 Association of enhanced superoxide generation by neutrophils with low superoxide scavenging activity of the peripheral blood, joint fluid, and their leukocyte components in rheumatoid arthritis: effects of slow-acting anti-rheumatic drugs and disease activity Clin Exp Rheumatol 9 149 155 1647912
20. T Pullar A Zoma HA Capell MF Khan DH Brown WE Smith 1987 Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine Br J Rheumatol 26 3 202 206 10.1093/rheumatology/26.3.202 1:STN:280:DyaL2s3hsVOqsQ%3D%3D 2884009
21. R Nordmann 1994 Alcohol and antioxidant systems Alcohol 29 5 513 522 1:CAS:528:DyaK2cXmvFCntb4%3D
22. KM Brown PC Morrice JR Arthur GG Duthie 1996 Effects of vitamin E supplementation on erythrocyte antioxidant defence mechanisms of smoking and non-smoking men Clin Sci 91 1 107 111 1:CAS:528:DyaK28XltVaisbo%3D 8774268
23. KM Toth EM Berger CJ Beehler JE Repine 1986 Erythrocytes from cigarette smokers contain more glutathione and catalase and protect endothelial cells from hydrogen peroxide better than do erythrocytes from nonsmokers Am Rev Respir Dis 134 2 281 284 1:CAS:528:DyaL28Xlt12htLY%3D 3740654
24. H Sies 1997 Oxidative stress: oxidants and antioxidants Exp Physiol 82 2 291 295 1:CAS:528:DyaK2sXivFemtLc%3D 9129943
25. JP Lekakis CM Papamichael AT Cimponeriu KS Stamatelopoulos TG Papaioannou J Kanakakis, et al. 2000 Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis Am J Cardiol 85 8 949 952 10.1016/S0002-9149(99)00907-8 1:STN:280:DC%2BD3c3ntlKlsg%3D%3D 10760332 (Pubitemid 30176131)
26. C Delles LU Zimmerli DJ McGrane CH Koh-Tan VL Pathi AJ McKay 2008 Vascular stiffness is related to superoxide generation in the vessel wall J Hypertens 26 5 946 955 10.1097/HJH.0b013e3282f7677c 1:CAS:528: DC%2BD1cXktl2rtb4%3D 18398337 (Pubitemid 351520982)